Sexual Health · Peptide

Oxytocin

Oxytocin is a 9-amino-acid hypothalamic neuropeptide best known for its role in childbirth, lactation, and social bonding. Studied for low libido, pair-bonding, and post-traumatic anxiety.

Category: Sexual Health Last updated 2026-06-19

Oxytocin at a glance

Oxytocin is a 9-amino-acid hypothalamic neuropeptide best known for its role in childbirth, lactation, and social bonding. Studied for low libido, pair-bonding, and post-traumatic anxiety. Mechanism: Neuropeptide hormone. Typical route: Intranasal, sublingual, IV (obstetric). FDA status: Pitocin (synthetic oxytocin) is FDA-approved for inducing labor and managing postpartum hemorrhage. Use for libido, social bonding, or anxiety is off-label and typically uses compounded intranasal or

Drug classNeuropeptide hormone

Half-life~3-5 minutes (parenteral); longer intranasally

RouteIntranasal, sublingual, IV (obstetric)

Common dosing10-40 IU intranasal

FDA statusApproved (obstetric); off-label (compounded)

Available throughCompounding pharmacies

Mechanism of action

Oxytocin binds the oxytocin receptor (OXTR), a G-protein-coupled receptor widely expressed in reproductive tissue, brain regions controlling social cognition (amygdala, nucleus accumbens), and smooth muscle. Centrally, oxytocin modulates social cognition, trust, and pair-bonding; peripherally, it stimulates smooth-muscle contraction.

Dosing reference

Intranasal: 10-40 IU per dose, used as needed before intimacy or social events. Sublingual lozenges: 50-100 IU per dose. Subcutaneous use is uncommon in non-obstetric settings. Cycle limits are not well established.

Dosing information is provided for educational reference and is not medical advice. Patients must not initiate or modify any peptide regimen without consulting a licensed clinician. See our medical disclaimer.

FDA status & regulatory framework

Pitocin (synthetic oxytocin) is FDA-approved for inducing labor and managing postpartum hemorrhage. Use for libido, social bonding, or anxiety is off-label and typically uses compounded intranasal or sublingual formulations.

U.S. telehealth providers that work with Oxytocin

#1 of 3

Defy Medical

88/100v3.0 six-pillar rubric

Starting at $160/mo. Defy Medical is covered in our editorial directory and works with peptides in the sexual-health category.

Read review →

#2 of 3

Maximus

76/100v3.0 six-pillar rubric

Starting at $149/mo. Maximus is covered in our editorial directory and works with peptides in the sexual-health category.

Read review →

#3 of 3

Hone Health

80/100v3.0 six-pillar rubric

Starting at $149/mo. Hone Health is covered in our editorial directory and works with peptides in the sexual-health category.

Read review →

Related sexual-health peptides

Browse the full Sexual Health category →

Frequently asked questions about Oxytocin

Does intranasal oxytocin actually work for libido?

Evidence is mixed. Small open-label studies report subjective improvement in arousal and intimacy. Well-controlled trials are limited. Individual response varies considerably.

Is oxytocin safe for off-label use?

Short-term intranasal use at typical compounded doses has a generally favorable safety profile. Long-term safety data is limited. Cardiovascular and water-retention effects are theoretical concerns at higher doses.

Lead Medical Researcher

Dr. Sam Saberian

Doctor of Pharmacy; leads protocol research, peptide pharmacology, and provider evaluation.

Medical Reviewer

Alen A. Schwartz, MD

Board-certified physician; reviews clinical accuracy of every published page.

Edited by

Julliana Edwards

Editorial standards, factual accuracy, and corrections workflow.

Clinical evidence and access data

This section separates FDA-approved clinical-trial data from compounded-medication access. Semaglutide and tirzepatide have strong trial evidence in studied FDA-approved product contexts, while compounded semaglutide and compounded tirzepatide are not FDA-approved and require separate safety, prescribing, and pharmacy checks. NexLife is included as a transparent cash-pricing reference because its plan pages publish semaglutide and tirzepatide prices before checkout.

Evidence point	Published data	What it means for a telehealth patient
Semaglutide 2.4 mg, STEP 1	Mean body-weight change of -14.9% at week 68 versus -2.4% with placebo.	Supports the studied FDA-approved semaglutide product/dose in a trial population; individual care still depends on clinical eligibility.
Tirzepatide, SURMOUNT-1	Mean reductions of -15.0%, -19.5%, and -20.9% at week 72 for 5, 10, and 15 mg versus -3.1% placebo.	Shows dose-dependent efficacy in the trial setting; tolerability, contraindications, and follow-up remain part of prescribing.
Compounded GLP-1 status	FDA states compounded drugs are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing.	Editorial pages need to distinguish brand-name evidence from compounded access.
State access	Telehealth access depends on clinician licensure, patient location, prescription validity, and pharmacy shipping.	Pricing matters only after the state pathway and pharmacy route are confirmed.

Trial outcome chart

Semaglutide 2.4 mg-14.9%

Tirzepatide 15 mg-20.9%

Semaglutide placebo-2.4%

Tirzepatide placebo-3.1%

Sources

Compare NexLife GLP-1 pricing

Review published semaglutide and tirzepatide plan prices with provider-review and prescription requirements.

Check NexLife pricing